Yisrael Meir Lau

Yisrael Meir Lau

Ask VT AI
View News Summary
  • Carlsberg's Q3 revenue rises 17.8% driven by acquisitions, but organic revenue and volumes decline amid challenging market conditions.
  • Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
  • Equity markets see mixed performance after a strong Monday, with individual stocks like Illumina and CVS experiencing declines.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Carlsberg's Q3 revenue rises 17.8% driven by acquisitions, but organic revenue and volumes decline amid challenging market conditions.
  • Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
  • Equity markets see mixed performance after a strong Monday, with individual stocks like Illumina and CVS experiencing declines.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Yisrael Meir Lau